• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

High Alcohol Consumption May Be Causally Tied to Stroke, PAD
TUESDAY, May 5, 2020 -- Higher alcohol consumption may be causally associated with an increased risk for stroke and peripheral artery disease, according to a study published online May 5 in Circulation: Genomic and Precision Medicine. Susanna C....
Source: Drugs.com - Pharma News - May 5, 2020 Category: Pharmaceuticals Source Type: news

Moderate Alcohol Consumption Does Not Up Stroke Risk in A-Fib
MONDAY, Jan. 25, 2021 -- For patients with atrial fibrillation (AF), low-to-moderate alcohol intake is not associated with an increased risk for stroke or other cardiovascular events, according to a study published online Jan. 25 in CMAJ, the...
Source: Drugs.com - Pharma News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Jan...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

Why you might think twice about wine with dinner
Having a single glass of wine with dinner every night could cut your life expectancy by about two years, according to an international study linking increased alcohol consumption with a higher risk of developing fatal diseases.   The research, published in the medical journal The Lancet, found that people who drank the equivalent of about six glasses of wine a week or more increased their risk of stroke, heart disease, heart failure, fatal hypertensive disease and fatal aortic aneurysm. The researchers…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 13, 2018 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate cancer, Janssen...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

America ’s Obsession With Alcohol- Will It Ever End?
Alcohol use, even at moderate amounts, is linked to a number of medical and health-related issues; including but not limited to an increase risk of cancers such as liver, esophagus, and breast; an increased risk of heart disease, stroke, and high blood pressure.
Source: Forbes.com Healthcare News - January 18, 2023 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news